brown university usa ranking 2018 Webinar series – canadian cancer survivor network

The CCSN webinar series is of interest to patients, survivors, family, friends, caregivers, and any member of the community interested in the best possible care and follow-up for cancer patients and survivors. Brown university ri the impact of volunteering and taking positive action to effect change are important elements in the transition to post-treatment life.

In his presentation, advocacy guru ryan clarke (advocacy solutions) walked through the steps to prepare for in-person meetings as an advocate for your cause. Topics include how to land the meeting, preparing a strategy and agenda, how to present your message and following up afterwards.

Dr. Gordon discusses how to decrease the risk of getting breast cancer, factors that influence risk and methods to find it as early as possible. This webinar was co-hosted by our partners at dense breasts canada, and there is a particular focus on the importance of knowing your breast density.

Dr. Paula gordon is clinical professor at the university of british columbia, and works full-time as breast radiologist, reading screening and diagnostic mammograms and performing image-guided breast biopsies. She is passionate about finding breast cancer early to decrease deaths from breast cancer and allow less aggressive treatment.

CCSN was joined by dr. Mamatha bhat (hepatologist at university health network in toronto), dr. Famous people who went to brown university amol mujoomder (interventional radiologist at london health sciences centre) and dr. Gregory powell (HCC patient & founder of shock trauma air rescue services foundation) for a webinar surrounding hepatocellular carcinoma (HCC), the most common form of primary liver cancer.

Our presenters defined what HCC is, discussed the current landscape for treatments and prognosis as well as new/innovative treatments, and insights from a liver cancer patient. The webinar also addressed concerns regarding lack of access and funding for life-saving treatments for liver cancer.

Statistics show that as of 2017, more than one million canadians have survived cancer for more than 10 years. Yet, the physical rehabilitation needs of cancer survivors in canada have received little attention and few services. Dr. Brown university shield jennifer M. Jones, phd, is a senior scientist and director of the cancer rehabilitation & survivorship program at the princess margaret cancer centre in toronto. Along with her colleague stephanie phan, clinical lead for the program, they provided an overview of her program, one of the best in the world and the only one of its kind in canada.

Maxime lê is a graduate of health sciences from the university of ottawa that has worn many hats for many roles. Brown university school of law chief among them is being a patient advisor for the ottawa hospital. Having frequently been a patient and having a passion for health and healthcare, he decided to get involved at the ottawa hospital to help improve care, research and advocate for patients. Maxime, while sharing his hands-on experience and insights, answered the questions that healthcare providers, researchers, or prospective patient advisors may have, such as: ”what does it mean to be a patient advisor?”, ”why is it important?”, and ”what impact does it have?”.

Ned was conceptualized and co-founded by our webinar presenter: dr. Andrew feifer, a urologic surgical oncologist at trillium health centre in toronto. Dr. Feifer evisioned a tool that would empower prostate cancer survivors by putting their health into their own hands and giving them more options to manage their own care.

This webinar discusses key elements of how to stay connected, experiencing positive emotions and close relationships after a cancer diagnosis including side effects from treatment resulting in erectile dysfunction, reviewing evidence from neuroscience on data related to meditation and intimacy, and learning practical ways to live an authentic life connected with those you love.

Oncologist dr. Rob rutledge reviewed the book radical remissions: surviving cancer against all odds by kelly turner, phd, and the nine key attitudes and behaviours found in people who have undergone a spontaneous remission. Though not promising a cure, dr. Brown university undergraduate enrollment rutledge shows there is much wisdom in adopting this proactive approach to a cancer diagnosis which can profoundly improve one’s health and happiness.

Robin markowitz and elizabeth lye from lymphoma canada discussed recent pcodr drug funding requests for innovative cancer therapies and how negative funding recommendations are affecting patient access to effective new treatments. To read the white paper discussed in this webinar, visit our website: http://bit.Ly/2q8duxm

The session was moderated by 3sixty public affairs’ bill dempster, who was joined by several canadian experts in pharmaceutical access, including a former director of the ontario public drug programs. This discussion reviewed the current state of public reimbursement for orphan medicines and examined how the emerging discussions about a new national pharmacare program will affect patient access to these medicines.

CCSN welcomed back helene hutchings to discuss anal and colorectal cancer in this educational webinar. Helene discussed the symptoms & risk factors of these cancers, as well as treatment options that are available. She also discussed prevention of anal and colorectal cancers and the benefits of peer-to-peer support groups.

Join alexandra chambers & oncologist dr. Craig earle with CADTH’s pan-canadian oncology drug review (pcodr) as they discuss the opportunities for clinicians to participate in the process and be part of the system, and how clinician input can help to inform cancer drug funding recommendations to enhance patient outcomes for canadians. 3Sixty public affairs’ bill dempster moderated this interactive webinar that included opportunities for participants to participate in polling and ask questions.

Bill dempster & guests louise binder & martine elias discussed the updates to the federal pharmaceutical price reform proposal, how patient leaders are responding and what steps they are taking to ensure that patients are being heard by decision makers.